Substituted tetracycline compounds for treatment of inflammatory skin disorders

US9481639B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9481639-B2
Application numberUS-201313987655-A
CountryUS
Kind codeB2
Filing dateAug 19, 2013
Priority dateDec 21, 2006
Publication dateNov 1, 2016
Grant dateNov 1, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Methods and compositions for the treatment of skin disorders (e.g., acne, rosacea) are described.

First claim

Opening claim text (preview).

The invention claimed is: 1. A method for treating a subject suffering from acne, comprising administering to the subject an effective amount of a substituted tetracycline compound that is or a pharmaceutically acceptable salt thereof. 2. A method for treating a subject suffering from rosacea, comprising administering to the subject an effective amount of a substituted tetracycline compound that is or a pharmaceutically acceptable salt thereof. 3. The method according to claim 1 , wherein the amount of substituted tetracycline compound administered to the subject is in a range of from 0.01 to 100 milligrams per kilogram of body weight of the subject. 4. The method according to claim 2 , wherein the amount of substituted tetracycline compound administered to the subject is in a range of from 0.01 to 100 milligrams per kilogram of body weight of the subject. 5. The method according to claim 1 , wherein the amount of substituted tetracycline compound administered to the subject is in a range of from 0.1 to 50 milligrams per kilogram of body weight of the subject. 6. The method according to claim 2 , wherein the amount of substituted tetracycline compound administered to the subject is in a range of from 0.1 to 50 milligrams per kilogram of body weight of the subject. 7. The method according to claim 1 , wherein the amount of substituted tetracycline compound administered to the subject is in a range of from 1 to 20 milligrams per kilogram of body weight of the subject. 8. The method according to claim 2 , wherein the amount of substituted tetracycline compound administered to the subject is in a range of from 1 to 20 milligrams per kilogram of body weight of the subject. 9. The method according to claim 1 , wherein the subject is a human. 10. The method according to claim 2 , wherein the subject is a human.

Assignees

Inventors

Classifications

  • Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00 · CPC title

  • Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] · CPC title

  • Anti-acne agents · CPC title

  • Antipsoriatics · CPC title

  • Drugs for dermatological disorders · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9481639B2 cover?
Methods and compositions for the treatment of skin disorders (e.g., acne, rosacea) are described.
Who is the assignee on this patent?
Paratek Pharm Innc
What technology area does this patent fall under?
Primary CPC classification C07C237/48. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Nov 01 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).